SUBSCRIBE
SUBSCRIBE

Roivant Sciences, Inc.

NEWS
Boy Wonder Ramaswamy's Roivant Bets $116 Million on Arbutus
Job Trends
Biotech Guru’s Roivant Sciences Could Soon Double Its Headcount in North Carolina
March 6, 2017
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Former Medivation CMO Takes Helm at Roivant Sciences-Takeda’s Newly Launched Company Myovant Sciences
June 6, 2016
 · 
2 min read
Load More
JOBS
IN THE PRESS
Business
Roivant and Sinovant Launch Cytovant Sciences in Partnership with Medigene to Develop Cellular Therapies in Asia
April 4, 2019
 · 
6 min read
Drug Development
Roivant Statement on Topline Results from EMPOWUR Phase 3 Study in Overactive Bladder
March 19, 2019
 · 
2 min read
Drug Development
Altavant Sciences to Present Data Supporting Planned Phase 2 Clinical Program for Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension at PVRI World Congress
January 31, 2019
 · 
4 min read
Pharm Country
Roivant Announces Corporate Updates and Webcast of Presentation at 37th Annual J.P. Morgan Healthcare Conference
January 6, 2019
 · 
3 min read
Pharm Country
Roivant Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference
January 2, 2019
 · 
1 min read
Business
Roivant Sciences and Daiichi Sankyo Enter into Broad Pipeline Partnership
December 19, 2018
 · 
2 min read
Business
Roivant Sciences and iNtRON Bio Sign Licensing Deal for Novel Anti-Superbugs Biologic SAL200
November 19, 2018
 · 
3 min read
Roivant Sciences Announces $200 Million Investment Round
November 13, 2018
 · 
1 min read
Deals
Roivant Adds Investigational Therapeutic for the Treatment of Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis to Pipeline
September 4, 2018
 · 
2 min read
Business
Roivant Sciences Provides Corporate Update
August 28, 2018
 · 
4 min read
Load More